We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03597282
Recruitment Status : Terminated (Closed due to historically slow enrollment compounded by the COVID-19 pandemic.)
First Posted : July 24, 2018
Last Update Posted : September 3, 2020
Apexigen, Inc.
Information provided by (Responsible Party):
BioNTech SE ( BioNTech US Inc. )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : May 5, 2020
Actual Study Completion Date : August 11, 2020